MfERG Quadrants | Patients (n = 30) | Controls (n = 30) | P-value |
---|---|---|---|
RT Q1 amplitude | 11.59 (3.53) | 18.97 (4.10) | < 0.001* |
RT Q1 peak time | 44.35 (4.38) | 43.08 (2.95) | 0.194 |
LT Q1amplitude | 11.86 (4.76) | 19.41 (3.34) | < 0.001* |
LT Q1peak time | 43.70 (2.94) | 42.58 (3.04) | 0.153 |
RT Q2 amplitude | 13.94 (3.85) | 18.42 (3.79) | < 0.001* |
RT Q2 peak time | 42.88 (3.14) | 42.64 (2.95) | 0.768 |
LT Q2 amplitude | 12.85 (3.05) | 19.55 (4.27) | < 0.001* |
LT Q2 peak time | 43.32 (3.25) | 42.95 (2.19) | 0.608 |
RT Q3 amplitude | 13 (3.94) | 19.44 (4.21) | < 0.001* |
RT Q3 peak time | 43.38 (3.29) | 42.84 (3.09) | 0.516 |
LT Q3 amplitude | 13.08 (4.16) | 19.35 (3.26) | < 0.001* |
LT Q3 peak time | 44.24 (2.62) | 43.47 (3.29) | 0.323 |
RT Q4 amplitude | 10.31 (3.25) | 18.14 (2.80) | < 0.001* |
RT Q4 peak time | 43.09 (2.96) | 42.65 (2.65) | 0.541 |
LT Q4 amplitude | 9.95 (3.11) | 18.64 (3.09) | < 0.001* |
LT Q4 peak time | 43.93 (3.42) | 43.54 (3.16) | 0.649 |